Amgen Inc. on Thursday mentioned it could lay off about 450 staff, or lower than 2% of its workforce, because it faces growing stress from drug costs and excessive inflation.
“We made these adjustments to realign our expense base within the face of intensifying stress on drug costs and excessive ranges of inflation in order that we are able to proceed to ship worth for our sufferers, employees and shareholders,” an Amgen spokesperson mentioned in an emailed assertion.
It’s…
